Explore

Trendline Trendline
PHARMAP 2026 Highlights Strategic Partnerships in Pharma Industry

PHARMAP 2026 Highlights Strategic Partnerships in Pharma Industry

PHARMAP 2026 Highlights Strategic Partnerships in Pharma Industry
Trendline Trendline
Roche Expands Partnership with C4 Therapeutics, Commits Over $1 Billion for Cancer Therapy Development

Roche Expands Partnership with C4 Therapeutics, Commits Over $1 Billion for Cancer Therapy Development

Roche Expands Partnership with C4 Therapeutics, Commits Over $1 Billion for Cancer Therapy Development
Trendline Trendline
Syneron Secures $150 Million to Advance Macrocyclic Peptide Development

Syneron Secures $150 Million to Advance Macrocyclic Peptide Development

Syneron Secures $150 Million to Advance Macrocyclic Peptide Development
Trendline Trendline
Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates

Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates

Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates
Trendline Trendline
Roche Invests $1 Billion in C4 Therapeutics for Degrader-Antibody Conjugates in Oncology

Roche Invests $1 Billion in C4 Therapeutics for Degrader-Antibody Conjugates in Oncology

Roche Invests $1 Billion in C4 Therapeutics for Degrader-Antibody Conjugates in Oncology
Trendline Trendline
FairJourney Bio Opens Cryo-EM Facility in San Diego to Enhance Antibody Discovery

FairJourney Bio Opens Cryo-EM Facility in San Diego to Enhance Antibody Discovery

FairJourney Bio Opens Cryo-EM Facility in San Diego to Enhance Antibody Discovery
Trendline Trendline
AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials

AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials

AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials
Trendline Trendline
Webinar Explores Analytical Strategies for Complex Antibody-Drug Conjugates

Webinar Explores Analytical Strategies for Complex Antibody-Drug Conjugates

Webinar Explores Analytical Strategies for Complex Antibody-Drug Conjugates
Trendline Trendline
Biotechnology Firms Drive Growth in High Potency API Market, Projected to Reach USD 69.13 Billion by 2035

Biotechnology Firms Drive Growth in High Potency API Market, Projected to Reach USD 69.13 Billion by 2035

Biotechnology Firms Drive Growth in High Potency API Market, Projected to Reach USD 69.13 Billion by 2035
Trendline Trendline
Gilead Sciences Shifts Focus to Integration After Series of Acquisitions

Gilead Sciences Shifts Focus to Integration After Series of Acquisitions

Gilead Sciences Shifts Focus to Integration After Series of Acquisitions
Trendline Trendline
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advancements

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advancements

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advancements
Trendline Trendline
ABK Biomedical and COR Development to Build Manufacturing Facility in Missouri for Cancer Treatment Device

ABK Biomedical and COR Development to Build Manufacturing Facility in Missouri for Cancer Treatment Device

ABK Biomedical and COR Development to Build Manufacturing Facility in Missouri for Cancer Treatment Device